Tiziana Life Sciences Ltd
TLSA
$0.81
$0.00991.24%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -13.73M | -15.71M | -17.69M | -18.60M | -19.50M |
| Total Depreciation and Amortization | 103.00K | 99.50K | 96.00K | 98.50K | 101.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.43M | 3.95M | 3.48M | 4.16M | 4.84M |
| Change in Net Operating Assets | 5.29M | 1.85M | -1.58M | -3.06M | -4.53M |
| Cash from Operations | -3.91M | -9.80M | -15.70M | -17.40M | -19.09M |
| Capital Expenditure | -14.00K | -7.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.00M | -1.00M | -1.00M | -500.50K | -1.00K |
| Cash from Investing | -1.01M | -1.01M | -1.00M | -500.50K | -1.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -151.00K | -135.00K | -119.00K | -105.50K | -92.00K |
| Issuance of Common Stock | 25.00K | 25.00K | 25.00K | 12.50K | -- |
| Repurchase of Common Stock | -- | -127.00K | -254.00K | -510.00K | -766.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 135.00K | 135.00K | 135.00K | 67.50K | -- |
| Cash from Financing | 9.00K | -102.00K | -213.00K | -535.50K | -858.00K |
| Foreign Exchange rate Adjustments | -556.00K | -292.00K | -28.00K | -257.50K | -487.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 247.00K | 494.00K |
| Net Change in Cash | -5.47M | -11.20M | -16.94M | -18.44M | -19.95M |